bolic effects of metformin on glucose andlactate metabolism in non-insulin-depen-dent diabetes mellitus. J Clin Endocrinol Metab 81:4059–4067, 1996 36. Hanefeld M, Brunetti P, Schernthaner GH, Matthews DR, Charbonnel BH: One-year glycemic control with a sulfonylureaplus pioglitazone versus a sulfonylureaplus metformin in patients with type 2diabetes. Diabetes Care 27:141–147, 2004 37. Tura A, Pacini G, Kautzky-Willer A, Lud- vik B, Prager R, Thomaseth K: Basal anddynamic proinsulin-insulin relationshipto assess beta-cell function during OGTTin metabolic disorders. Am J Physiol Endo- crinol Metab 285:E155–E162, 2003 38. DeFronzo R, Ratner R, Han J, Kim DD, Fineman MS, Baron AD: Effects of ex-enatide (synthetic exendin-4) on glyce-mic control and weight over 30 weeks inmetformin-treated patients with type 2diabetes (Abstract). American DiabetesAssociation 64th Annual Scientiﬁc Ses-sions, 2004 (6-LB late-breaking abstract). Buse and Associates